By the year 2040, there will be 1.7 million people in the UK living with dementia, according to the latest concerning forecasts published in leading medical journal The Lancet.
Brits should be able to get the new Alzheimer s drug donanemab which can slow the disease to a crawl in the next two years with experts urging regulators to do all they can to approve the treatment.
Can new drug donanemab really slow the growth of Alzheimer s disease? firstpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from firstpost.com Daily Mail and Mail on Sunday newspapers.
Questions about whether donanemab - and two similar drugs from US pharma giants - are really the answer to combating the devastating disease remain unanswered.